Skip to main content

Table 2 Proportional weights (%) assigned to medicines in different burden of disease scenarios

From: SDG indicator 3.b.3 – an analysis of its robustness and challenges for measuring access to medicines for children

Medicine

Scenario

A (base case)

B

C

D

E

code 370; DB multiplied

code 370; DB divided

code 20; DB multiplied

code 20; DB divided

No weighting

Oral rehydration salts

8.5

12.1

3.9

5.6

5.3

Zinc sulphate

8.5

12.1

3.9

5.6

5.3

Phenytoin

0.3

0.3

0.1

0.1

5.3

Valproic acid

0.3

0.3

0.1

0.1

5.3

Diazepam

0.3

0.3

0.1

0.1

5.3

Ferrous salt

0.8

1.1

0.4

0.5

5.3

Mebendazole

0.8

1.1

0.4

0.5

5.3

Artemether + lumefantrine

6.2

8.8

2.9

4.1

5.3

Vitamin A

1.8

5.3

0.9

2.5

5.3

Paracetamol

4.5

4.0

4.5

3.3

5.3

Morphine

4.5

4.0

4.5

3.3

5.3

Ibuprofen

4.5

4.0

4.5

3.3

5.3

Amoxicillin

13.4

9.6

12.4

8.8

5.3

Ampicillin

13.4

9.6

12.4

8.8

5.3

Benzylpenicillin

13.4

9.6

12.4

8.8

5.3

Gentamicin

13.4

9.6

12.4

8.8

5.3

Ceftriaxone

2.7

3.9

12.0

17.7

5.3

Cefotaxime

2.7

3.9

12.0

17.7

5.3

Procaine benzylpenicillin

0.2

0.5

0.1

0.3

5.3

Total

100%

100%

100%

100%

100%

  1. A = base case scenario, using GHE code 370 as a proxy for infectious diseases. B = GHE code 370, and the burden of a disease is divided over all medicines for treating that specific disease. C = GHE code 20 (original methodology). D = GHE code 20, and the burden of a disease is divided over all medicines for treating that specific disease. E = no DB weighting (e.g. equal weights for all medicines)